Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Eli Lilly
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
tabalumab
(LY2127399) / Eli Lilly
insulin peglispro
(LY2605541) / Eli Lilly
Dirucotide
(MBP8298) / Eli Lilly
Jardiance
(empagliflozin) / Eli Lilly, Boehringer Ingelheim
Olumiant
(baricitinib) / Eli Lilly
Basaglar
(insulin glargine biosimilar) / Boehringer Ingelheim, Eli Lilly
Humalog ILPS
(insulin lispro protamine suspension) / Eli Lilly
